February 22, 2021 | Portfolio News

Personal Genome Diagnostics Announces Close of $103 Million Series C Financing

21

Novel FDA PMA & de novo 510k approvals

60

U.S. Commercial Product Launches

39

Level I Clinical Trials

31

Strategic Financings

31

Exits by IPO or M&A